Ben Philpot, PhD
December 19, 2019

Defining Treatment Parameters for Angelman Syndrome

Ben Philpot, Ph.D. – University of North Carolina, Chapel Hill Ype Elgersma, Ph.D. – Erasmus Medical Center, Rotterdam, Netherlands $400,000 (2 years – $200,000 per institute) A previously developed mouse model for Angelman syndrome (AS) enables the maternal copy of […]

Read more
December 14, 2019

Validation of biomarkers for Angelman syndrome clinical trials

Ben Philpot, Ph.D. – University of North Carolina-Chapel Hill Heather Hazlett, Ph.D. – Carolina Institute of Developmental Disabilities at University of North Carolina-Chapel Hill Ron Thibert, M.D. – Massachusetts General Hospital $295,970 (2 years) This unique research project is the […]

Read more
Christopher Keary, MD
December 14, 2019

Evaluating Anxiety in Individuals with Angelman Syndrome

$181,800 Many families of individuals with Angelman syndrome express concern to their doctors about anxiety in their loved one. However, very little is understood about anxiety in individuals with AS at the clinical level. Many clinicians feel that once physical […]

Read more